{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T20:55:35Z","timestamp":1763499335714},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Cariverona Foundation","award":["2014.0851","2015.0872"],"award-info":[{"award-number":["2014.0851","2015.0872"]}]}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ejim.2017.03.019","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T03:31:47Z","timestamp":1491622307000},"page":"10-17","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["A decade of progress on the genetic basis of coronary artery disease. Practical insights for the internist"],"prefix":"10.1016","volume":"41","author":[{"given":"Domenico","family":"Girelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Piubelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Corrocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliviero","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2017.03.019_bb0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrcardio.2014.26","article-title":"Epidemiological studies of CHD and the evolution of preventive cardiology","volume":"11","author":"Wong","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0010","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","article-title":"Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: quantifying the epidemiological transition","volume":"386","author":"Murray","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0015","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.291.18.2204","article-title":"Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring","volume":"291","author":"Lloyd-Jones","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2017.03.019_bb0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jacc.2010.07.054","article-title":"Parental history and myocardial infarction risk across the world: the INTERHEART study","volume":"57","author":"Chow","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng1297-387","article-title":"A twin-pronged attack on complex traits","volume":"17","author":"Martin","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0030","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199404143301503","article-title":"Genetic susceptibility to death from coronary heart disease in a study of twins","volume":"330","author":"Marenberg","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tcm.2014.10.008","article-title":"A genetic basis for coronary artery disease","volume":"25","author":"Roberts","year":"2015","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10519-004-5586-1","article-title":"Genetic influences on CHD-death and the impact of known risk factors: comparison of two frailty models","volume":"34","author":"Zdravkovic","year":"2004","journal-title":"Behav Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MOL.0000000000000160","article-title":"Gene-environment interaction in dyslipidemia","volume":"26","author":"Cole","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0050","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Global Lipids Genetics C","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0055","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1161\/CIRCRESAHA.112.300387","article-title":"Advances in blood pressure genomics","volume":"112","author":"Munroe","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.ejim.2017.03.019_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature10405","article-title":"Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk","volume":"478","author":"International Consortium for Blood Pressure Genome-Wide Association S","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2017.03.019_bb0065","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cell.2012.03.001","article-title":"Genetics of human cardiovascular disease","volume":"148","author":"Kathiresan","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejim.2017.03.019_bb0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrg1805","article-title":"Genetic susceptibility to coronary artery disease: from promise to progress","volume":"7","author":"Watkins","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra0905980","article-title":"Genomewide association studies and assessment of the risk of disease","volume":"363","author":"Manolio","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrg.2016.49","article-title":"Coming of age: ten years of next-generation sequencing technologies","volume":"17","author":"Goodwin","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev-med-051010-162644","article-title":"Human genome sequencing in health and disease","volume":"63","author":"Gonzaga-Jauregui","year":"2012","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0090","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/CIRCULATIONAHA.117.026857","article-title":"Mendelian randomization: using natural genetic variation to assess the causal role of modifiable risk factors in observational studies","volume":"135","author":"Neeland","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.03.019_bb0095","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/eurheartj\/ehu208","article-title":"Mendelian randomization studies in coronary artery disease","volume":"35","author":"Jansen","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2017.03.019_bb0100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev-genom-090314-050016","article-title":"Mendelian randomization: new applications in the coming age of hypothesis-free causality","volume":"16","author":"Evans","year":"2015","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"Suppl. 1","key":"10.1016\/j.ejim.2017.03.019_bb0105","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1111\/jth.12924","article-title":"Use of genetic data to guide therapy in arterial disease","volume":"13","author":"Ross","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.03.019_bb0110","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.109.909309","article-title":"Genetic cardiovascular risk prediction: will we get there?","volume":"122","author":"Thanassoulis","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.03.019_bb0115","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1055\/s-0029-1242721","article-title":"Genetic architecture of coronary artery disease in the genome-wide era: implications for the emerging \u201cgolden dozen\u201d loci","volume":"35","author":"Girelli","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ejim.2017.03.019_bb0120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1538-7836.2007.02405.x","article-title":"No praise for folly: genomics will never be useful in arterial thrombosis","volume":"5","author":"Reitsma","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.03.019_bb0125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa072366","article-title":"Genomewide association analysis of coronary artery disease","volume":"357","author":"Samani","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0130","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.1142447","article-title":"A common allele on chromosome 9 associated with coronary heart disease","volume":"316","author":"McPherson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ejim.2017.03.019_bb0135","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1142842","article-title":"A common variant on chromosome 9p21 affects the risk of myocardial infarction","volume":"316","author":"Helgadottir","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ejim.2017.03.019_bb0140","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrg2344","article-title":"Genome-wide association studies for complex traits: consensus, uncertainty and challenges","volume":"9","author":"McCarthy","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0145","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/j.jacc.2016.10.039","article-title":"Genetics: implications for prevention and management of coronary artery disease","volume":"68","author":"Assimes","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0150","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2016.11.056","article-title":"Systematic evaluation of pleiotropy identifies 6 further loci associated with coronary artery disease","volume":"69","author":"Webb","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng.2480","article-title":"Large-scale association analysis identifies new risk loci for coronary artery disease","volume":"45","author":"Consortium","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0160","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/ng.327","article-title":"Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants","volume":"41","author":"Myocardial Infarction Genetics C","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng.784","article-title":"Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease","volume":"43","author":"Schunkert","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0170","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.1073\/pnas.0903103106","article-title":"Potential etiologic and functional implications of genome-wide association loci for human diseases and traits","volume":"106","author":"Hindorff","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2017.03.019_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Consortium","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2017.03.019_bb0180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/scientificamerican1103-46","article-title":"The unseen genome: gems among the junk","volume":"289","author":"Gibbs","year":"2003","journal-title":"Sci Am"},{"key":"10.1016\/j.ejim.2017.03.019_bb0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrg3722","article-title":"The rise of regulatory RNA","volume":"15","author":"Morris","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0190","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0195","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MOL.0b013e3283654e7c","article-title":"From genotype to phenotype in human atherosclerosis\u2014recent findings","volume":"24","author":"Holdt","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0200","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI70391","article-title":"Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis","volume":"124","author":"Kojima","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2017.03.019_bb0205","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature08801","article-title":"Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice","volume":"464","author":"Visel","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2017.03.019_bb0210","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1161\/ATVBAHA.113.301218","article-title":"Multilocus genetic risk scores for coronary heart disease prediction","volume":"33","author":"Ganna","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.atherosclerosis.2015.03.022","article-title":"A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals","volume":"240","author":"Krarup","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejim.2017.03.019_bb0220","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehv462","article-title":"Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history","volume":"37","author":"Tada","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2017.03.019_bb0225","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1093\/eurheartj\/ehw450","article-title":"Genomic prediction of coronary heart disease","volume":"37","author":"Abraham","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2017.03.019_bb0230","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.cjca.2016.05.014","article-title":"Impact of a genetic risk score on myocardial infarction risk across different ethnic populations","volume":"32","author":"Joseph","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0235","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0240","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fgene.2014.00254","article-title":"Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for complex traits: coronary heart disease as an example","volume":"5","author":"Goldstein","year":"2014","journal-title":"Front Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0245","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/CIRCGENETICS.116.001645","article-title":"Predicting incident coronary heart disease many markers at a time","volume":"9","author":"Bush","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0250","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCGENETICS.116.001522","article-title":"Clinical utility of multimarker genetic risk scores for prediction of incident coronary heart disease: a cohort study among over 51 thousand individuals of European ancestry","volume":"9","author":"Iribarren","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0255","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ng.608","article-title":"Common SNPs explain a large proportion of the heritability for human height","volume":"42","author":"Yang","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0260","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2017.03.019_bb0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/456018a","article-title":"Personal genomes: the case of the missing heritability","volume":"456","author":"Maher","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2017.03.019_bb0270","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0140-6736(14)61730-X","article-title":"Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials","volume":"385","author":"Mega","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0275","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.116.024436","article-title":"Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting","author":"Natarajan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.03.019_bb0280","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic risk, adherence to a healthy lifestyle, and coronary disease","volume":"375","author":"Khera","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0285","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2017.03.019_bb0290","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2017.03.019_bb0295","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2017.03.019_bb0300","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0305","first-page":"1157","article-title":"Tracing of patients with familial hypercholesterolemia in the Netherlands","volume":"143","author":"Umans-Eckenhausen","year":"1999","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.ejim.2017.03.019_bb0310","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","volume":"303","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2017.03.019_bb0315","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1515\/CCLM.2008.135","article-title":"Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing","volume":"46","author":"Starr","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0320","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.03.019_bb0325","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000341889","article-title":"Public health action in genomics is now needed beyond newborn screening","volume":"15","author":"Bowen","year":"2012","journal-title":"Public Health Genomics"},{"key":"10.1016\/j.ejim.2017.03.019_bb0330","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/CIRCRESAHA.115.306360","article-title":"Are genetic tests for atherosclerosis ready for routine clinical use?","volume":"118","author":"Paynter","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ejim.2017.03.019_bb0335","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf7000","article-title":"Genetic identification of familial hypercholesterolemia within a single U.S. health care system","volume":"354","author":"Abul-Husn","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejim.2017.03.019_bb0340","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.113.002033","article-title":"Evolution and emergence of therapeutic monoclonal antibodies: what cardiologists need to know","volume":"127","author":"Foltz","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.03.019_bb0345","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jacl.2010.08.015","article-title":"Novel therapies and new targets of treatment for familial hypercholesterolemia","volume":"4","author":"Goldberg","year":"2010","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0350","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJMcibr1613559","article-title":"Targeting therapeutic oligonucleotides","volume":"376","author":"Levin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0355","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.114.301621","article-title":"PCSK9: a key modulator of cardiovascular health","volume":"114","author":"Seidah","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.ejim.2017.03.019_bb0360","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0365","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0370","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.115.016080","article-title":"Proprotein convertase subtilisin\/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk","volume":"132","author":"Bergeron","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.03.019_bb0375","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cell.2016.05.016","article-title":"PCSK9 inhibitors","volume":"165","author":"Natarajan","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejim.2017.03.019_bb0380","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1316222","article-title":"A 52-week placebo-controlled trial of evolocumab in hyperlipidemia","volume":"370","author":"Blom","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0385","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2017.03.019_bb0390","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0395","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0400","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","article-title":"A new serum type system in man--the Lp system","volume":"59","author":"Berg","year":"1963","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.ejim.2017.03.019_bb0405","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.2530631","article-title":"The mysteries of lipoprotein(a)","volume":"246","author":"Utermann","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.ejim.2017.03.019_bb0410","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/01.ATV.12.10.1214","article-title":"Apo(a) isoforms predict risk for coronary heart disease. A study in six populations","volume":"12","author":"Sandholzer","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.ejim.2017.03.019_bb0415","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0420","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2017.03.019_bb0425","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1161\/ATVBAHA.114.303462","article-title":"A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk","volume":"34","author":"Kyriakou","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0430","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.jacc.2016.10.033","article-title":"Phenotypic characterization of genetically lowered human lipoprotein(a) levels","volume":"68","author":"Emdin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0435","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(16)31009-1","article-title":"Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials","volume":"388","author":"Viney","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0440","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1194\/jlr.R052258","article-title":"Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humans","volume":"57","author":"Graham","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ejim.2017.03.019_bb0445","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2014.01.006","article-title":"Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials","volume":"63","author":"Raal","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0450","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.116.025253","article-title":"Effects of PCSK9 inhibition with alirocumab on lipoprotein metabolism in healthy humans","volume":"135","author":"Reyes-Soffer","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.03.019_bb0455","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCULATIONAHA.116.025897","article-title":"Unpacking and understanding the impact of proprotein convertase subtilisin\/kexin type 9 inhibitors on apolipoprotein B metabolism","volume":"135","author":"Packard","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.03.019_bb0460","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/eurheartj\/ehu500","article-title":"Triglycerides on the rise: should we swap seats on the seesaw?","volume":"36","author":"Libby","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2017.03.019_bb0465","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ejim.2017.03.019_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbalip.2014.03.013","article-title":"Physiological regulation of lipoprotein lipase","author":"Kersten","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejim.2017.03.019_bb0475","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Emerging Risk Factors C","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2017.03.019_bb0480","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","article-title":"Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies","volume":"375","author":"Triglyceride Coronary Disease Genetics C","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0485","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1126\/science.351.6278.1126","article-title":"Lipid biology. Why high \u2018good cholesterol\u2019 can be bad news","volume":"351","author":"Couzin-Frankel","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejim.2017.03.019_bb0490","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0495","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejim.2017.03.019_bb0500","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/gb-2008-9-8-109","article-title":"Isolated populations and complex disease gene identification","volume":"9","author":"Kristiansson","year":"2008","journal-title":"Genome Biol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0505","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","article-title":"Identification of scavenger receptor SR-BI as a high density lipoprotein receptor","volume":"271","author":"Acton","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejim.2017.03.019_bb0510","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa1508419","article-title":"Variant ASGR1 associated with a reduced risk of coronary artery disease","volume":"374","author":"Nioi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0515","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0520","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Tg, Hdl Working Group of the Exome Sequencing Project NHL","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0525","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"Jorgensen","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0530","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1126\/science.1161524","article-title":"A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection","volume":"322","author":"Pollin","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ejim.2017.03.019_bb0535","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","article-title":"Inactivating variants in ANGPTL4 and risk of coronary artery disease","volume":"374","author":"Dewey","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0540","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","article-title":"Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease","volume":"374","author":"Myocardial Infarction","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0545","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature13917","article-title":"Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction","volume":"518","author":"Do","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2017.03.019_bb0550","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ng.3561","article-title":"Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease","volume":"48","author":"Helgadottir","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0555","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1373\/clinchem.2016.258244","article-title":"Demystifying HDL cholesterol-A \u201chuman knockout\u201d to the rescue?","volume":"63","author":"Khera","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejim.2017.03.019_bb0560","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2017.03.019_bb0565","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMe1604773","article-title":"The sialylation pathway and coronary artery disease","volume":"374","author":"Tybjaerg-Hansen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0570","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pharmthera.2013.11.008","article-title":"Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment","volume":"141","author":"Varbo","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ejim.2017.03.019_bb0575","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0580","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1400283","article-title":"Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia","volume":"373","author":"Gaudet","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0585","first-page":"562","article-title":"Gene therapy. Inhibiting apoC-III synthesis in patients with hypertriglyceridaemia","volume":"12","author":"Huynh","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejim.2017.03.019_bb0590","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11883-016-0614-1","article-title":"Why is apolipoprotein CIII emerging as a novel therapeutic target to reduce the burden of cardiovascular disease?","volume":"18","author":"Taskinen","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ejim.2017.03.019_bb0595","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1538-7836.2009.03720.x","article-title":"Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation","volume":"8","author":"Olivieri","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.03.019_bb0600","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd4051","article-title":"Validating therapeutic targets through human genetics","volume":"12","author":"Plenge","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ejim.2017.03.019_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcm.2016.08.008","article-title":"Leveraging human genetics to guide drug target discovery","author":"Stitziel","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.ejim.2017.03.019_bb0610","doi-asserted-by":"crossref","DOI":"10.1038\/nrg.2016.160","article-title":"Genetics of coronary artery disease: discovery, biology and clinical translation","author":"Khera","year":"2017","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0615","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.344.6185.687","article-title":"The hunt for missing genes","volume":"344","author":"Kaiser","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ejim.2017.03.019_bb0620","doi-asserted-by":"crossref","first-page":"E455","DOI":"10.1073\/pnas.1322563111","article-title":"Searching for missing heritability: designing rare variant association studies","volume":"111","author":"Zuk","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2017.03.019_bb0625","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/527S14a","article-title":"Deep phenotyping: the details of disease","volume":"527","author":"Delude","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2017.03.019_bb0630","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tig.2014.02.003","article-title":"Explaining additional genetic variation in complex traits","volume":"30","author":"Robinson","year":"2014","journal-title":"Trends Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0635","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ng.307","article-title":"New susceptibility locus for coronary artery disease on chromosome 3q22.3","volume":"41","author":"Erdmann","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0640","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"Wellcome Trust Case Control C","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejim.2017.03.019_bb0645","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(10)61996-4","article-title":"Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies","volume":"377","author":"Reilly","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0650","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/ng.323","article-title":"Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction","volume":"41","author":"Gudbjartsson","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2017.03.019_bb0655","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ng.782","article-title":"A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease","volume":"43","author":"Coronary Artery Disease Genetics C","year":"2011","journal-title":"Nat Genet"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517301231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517301231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T16:29:55Z","timestamp":1568996995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517301231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":131,"alternative-id":["S0953620517301231"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.03.019","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A decade of progress on the genetic basis of coronary artery disease. Practical insights for the internist","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}